PharmaLogic Holdings Corp. announced on November 9, 2026, a definitive agreement to acquire the CDMO business and Springfield, New Jersey manufacturing facility from Lantheus Holdings, Inc. (NASDAQ:LNTH), with financial terms not disclosed.
Lucid Group, Inc. filed an 8-K earnings release on November 9, 2026, disclosing third-quarter 2026 financial results including $350 million in revenue, a 30% sequential reduction in free cash flow consumption, and a $1.75 billion expansion of its delayed draw term loan facility with …
Qualys, Inc. (NASDAQ:QLYS) reported its third-quarter 2026 financial results on November 9, 2026, disclosing revenues of $188.0 million and raising its full-year 2026 revenue guidance to $736.9 million to $738.9 million.
Csquare, Inc. (NYSE:CSQR) filed its third-quarter 2026 earnings disclosure on November 9, 2026, reporting revenue of $302.3 million, record bookings, and balance sheet changes following its July 2026 initial public offering.
The Generation Essentials Group filed an 8-K on November 9, 2026, announcing an extraordinary general meeting scheduled for December 7, 2026, at which shareholders will vote on a 15-for-1 share consolidation intended to help the company regain compliance with NYSE minimum average closing share …
National Health Investors, Inc. filed its third-quarter 2026 earnings disclosure on November 9, 2026, reporting results for the quarter ended September 30, 2026, highlighted by a $541.6 million gain on the sale of its National Healthcare Corporation leased portfolio.
Shutterstock, Inc. filed a definitive proxy statement on November 9, 2026, notifying stockholders of its 2026 Annual Meeting of Stockholders scheduled for December 22, 2026, at 10:00 a.m. Eastern Time via live webcast.
Jane Street Group, LLC filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 4,246,421 shares of AXT Inc common stock, representing 6.5% of the class, as of the triggering event date of November 3, 2026.
Xiaofeng Ma and affiliated entities filed Amendment No. 11 to a Schedule 13D with the SEC on November 9, 2026, disclosing updated beneficial ownership of Common Shares in ATA Creativity Global following the termination of Ma Family Trust on September 25, 2026.
Myriad Genetics, Inc. filed a Form 8-K on November 9, 2026, disclosing that its Compensation and Human Capital Committee approved one-time retention stock option awards for three named executive officers on November 6, 2026.